Zydus Lifesciences received approval for Isosorbide Mononitrate, shares up

Zydus Lifesciences’ shares rose 1.40% as USFDA approves Isosorbide Mononitrate Tablets, used to treat chest pain, for distribution

Subscribe To Our Free Newsletter